The impact of selectins on mortality in stable carotid atherosclerosis
Matthias Hoke, Max-Paul Winter, Oswald Wagner
1Georg Goliasch, MD, PhD, Division of Cardiology, Department of Internal Medicine II, Medical University Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria, Tel.: +43 1 40400 46140, Fax: +43 1 40400 42160,
Insights
Plasma levels of intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) predict mortality in patients with carotid atherosclerosis. These selectins indicate endothelial activation and aid in risk stratification for cardiovascular events.
Area of Science:
- Cardiovascular Biology
- Immunology
- Biomarkers
Background:
- Cellular adhesion molecules, specifically selectins, facilitate inflammatory cell recruitment to the arterial wall, contributing to atherosclerotic plaque formation.
- Intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), and endothelial-leukocyte adhesion molecule 1 (ELAM-1/E-selectin) mediate leukocyte attachment and are implicated in atherosclerotic plaque destabilization.
Purpose of the Study:
- To investigate the association between plasma selectin levels and adverse clinical outcomes in patients with carotid atherosclerosis.
- To determine if ICAM-1, VCAM-1, and E-selectin can serve as predictors of cardiovascular and all-cause mortality.
Main Methods:
- Prospective study of 855 patients with sonographically confirmed carotid atherosclerosis.
- Median follow-up of 6.2 years, with monitoring for all-cause and cardiovascular mortality.
- Statistical analysis using adjusted hazard ratios (HR) and confidence intervals (CI) to assess the association between selectin levels and mortality.
Main Results:
- Elevated plasma levels of ICAM-1 and VCAM-1 were significantly associated with increased cardiovascular mortality (HR: 3.43 and 2.51, respectively) and all-cause mortality when comparing the highest to lowest quartiles.
- No significant association was found between E-selectin levels and all-cause or cardiovascular mortality.
- ICAM-1 and VCAM-1 were identified as strong, independent predictors of mortality in this patient cohort.
Conclusions:
- Plasma ICAM-1 and VCAM-1 levels are significant predictors of all-cause and cardiovascular mortality in patients with stable carotid atherosclerosis.
- These selectins, elevated during endothelial activation, may serve as valuable biomarkers for monitoring anti-atherosclerotic therapy and identifying high-risk individuals.
- Further research could explore their utility in guiding therapeutic strategies for carotid atherosclerosis management.
Abstract:
Cellular adhesion molecules also known as selectins promote recruitment of inflammatory cells into the arterial wall where they interact with lipid particles leading subsequently to plaque formation. The intercellular adhesion molecule-1 (ICAM-1), the vascular cell adhesion molecule-1 (VCAM-1) and the endothelial-leukocyte adhesion molecule 1 (ELAM-1) also known as E-selectin mediate the attachment of leukocytes and have been implicated in the destabilisation of atherosclerotic plaques. Therefore, we hypothesised that plasma selectin levels are associated with adverse clinical outcome. We prospectively studied 855 patients with sonographically confirmed carotid atherosclerosis. During a median follow-up of 6.2 years, corresponding to 5,551 overall person-years, 275 patients (26 %) died. We detected a significant association between cardiovascular mortality and ICAM-1 (adjusted hazard ratio [HR]: 3.43, 95 % confidence interval [CI] 2.00-5.88, p< 0.001) as well as VCAM-1 (adjusted HR: 2.51, 95 %CI 1.45-4.34, p=0.001) when comparing the fourth with the first quartile. Comparable results were obtained for all-cause mortality. In contrast, we could not detect a significant association between E-selectin and all-cause or cardiovascular mortality. We identified the selectins ICAM-1 and VCAM-1 as strong and independent predictors of all-cause and cardiovascular mortality in patients with stable carotid atherosclerosis. These molecules are elevated in states of endothelial activation and might assist to monitor anti-atherosclerotic therapy and select those patients with carotid atherosclerosis, who are at higher risk for cardiovascular events.
Related Concept Videos
Selectins
Intracellular Signaling Affects Focal Adhesions
Some...
Atherosclerosis III: Management
Atherosclerosis I: Introduction
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology


